Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)

TerminatedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Non-small Cell Lung CancerNeoantigenNext-generation SequencingBiomarker
Trial Locations (1)

400000

Second Affiliated Hospital of Army Medical University, Chongqing

All Listed Sponsors
collaborator

Xinqiao Hospital of Chongqing

OTHER

collaborator

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

collaborator

Shanghai Chest Hospital

OTHER

collaborator

Wuhan University

OTHER

collaborator

Renmin Hospital of Wuhan University

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

Southwest Hospital, China

OTHER

collaborator

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER

collaborator

People's Hospital of Chongqing

OTHER

collaborator

Sichuan Cancer Hospital and Research Institute

OTHER

collaborator

The Second Affiliated Hospital of Kunming Medical University

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

The Affiliated Hospital Of Southwest Medical University

OTHER

collaborator

Guizhou Provincial People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Shaanxi Provincial Cancer Hospital

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

Fujian Provincial Hospital

OTHER

collaborator

Peking University Shenzhen Hospital

OTHER

collaborator

Affiliated Cancer Hospital of Shantou University Medical College

OTHER

collaborator

The Second Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

OTHER

lead

GeneCast Biotechnology Co., Ltd.

INDUSTRY

NCT04923802 - Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION) | Biotech Hunter | Biotech Hunter